MedTrace Logo

Prognosis of Patients With Compete Left Bundle Branch Block

NCT03096678 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2017-04-11

No results posted yet for this study

Summary

The investigators sought to evaluate the morphological and functional changes, risk stratification and prognosis of patients of participants with compete left bundle branch block (CLBBB).

The conduction of this study was largely due to the increased clinical requirement, which reflected the increased awareness among physicians of heart failure due to asynchronous cardiac function caused by CLBBB. The investigators also aim to figure out the time point or CMR parameters for cardiac resynchronization therapy in patients with CLBBB.

Conditions

  • Bundle-Branch Block, Left
  • Cardiac Failure
  • ICD/Pacemaker Implantation
  • Cardiovascular Magnetic Resonance Imaging

Interventions

DIAGNOSTIC_TEST

Cardiac Magnetic Resonance Imaging

Using a comprehensive MR study (Function, LGE, Tissue Characterization, Strain, T1/T2 mapping) to predict the outcome of LBBB with different cardiac function.

Sponsors & Collaborators

  • Beijing Anzhen Hospital

    collaborator OTHER

  • China-Japan Friendship Hospital

    collaborator OTHER

  • Peking Union Medical College Hospital

    collaborator OTHER

  • Xuanwu Hospital, Beijing

    collaborator OTHER

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Chinese Academy of Medical Sciences, Fuwai Hospital

    lead OTHER

Principal Investigators

  • Minjie Lu, MD,PhD · Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical, Sciences and Peking Union Medical College

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-01
Primary Completion
2020-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03096678 on ClinicalTrials.gov